Saxenda and Wegovy are in a class of drugs called GLP-1 agonists, which mimic glucagon-like peptide 1, a gastrointestinal hormone that helps regulate glucose
Whether these overlapping effects produce additive, synergistic, or antagonistic outcomes in humans is not established
The 2013 Journal of Neurochemistry paper by McCoy et al
As a key transcription factor for antioxidant stress, NRF2 regulates ferroptosis-related target genes by promoting the expression of those involved in redox homeostasis, such as the glutathione (GSH) synthesis pathway genes (e.g., SLC7A11, SLC3A2, GCLM, and GCLC), which play a critical role in neutralizing ROS and lipid peroxides [31]
Ozempic (semaglutide) is a brand-name subcutaneous injection prescribed for managing type 2 diabetes, among other uses